Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
by Patrick C. Walsh Janet Farrar Worthington
Our Price: $10.19
Used from: $1.62

The Definitive Guide to Prostate Cancer: Everything You Need to Know about Conventional and Integrative Therapies
The Definitive Guide to Prostate Cancer: Everything You Need to Know about Conventional and Integrative Therapies
by Dr. Aaron Katz
Our Price: $10.19
Used from: $9.16

Winning the Battle Against Prostate Cancer: Get the Treatment That is Right for You
Winning the Battle Against Prostate Cancer: Get the Treatment That is Right for You
by Gerald Chodak
Our Price: $11.37
Used from: $9.48

The Decision: Your prostate biopsy shows cancer. Now what?: Medical insight, personal stories, and humor by a urologist who has been where you are now.
The Decision: Your prostate biopsy shows cancer. Now what?: Medical insight, personal stories, and humor by a urologist who has been where you are now.
by John C. McHugh M.D.
Our Price: $13.24
Used from: $12.14

Prostate Cancer Survivors Speak Their Minds: Advice on Options, Treatments, and Aftereffects
Prostate Cancer Survivors Speak Their Minds: Advice on Options, Treatments, and Aftereffects
by Arthur L. Burnett II Norman Morris
Our Price: $11.53
Used from: $0.01



Prostate Cancer Prevention Links


<< 1 2 3 >>




Prostate Cancer Prevention News


Triple Analysis: Breast Cancer, Prostate Cancer and Angiogenesis - MarketWatch (press release)


Triple Analysis: Breast Cancer, Prostate Cancer and Angiogenesis
MarketWatch (press release)
6, 2012 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the ...
Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to ...Sacramento Bee

all 14 news articles »

Read more...


Chemoprevention of prostate cancer: An updated view - Abstract - UroToday


Chemoprevention of prostate cancer: An updated view - Abstract
UroToday
METHODS: Review of recently published updates of large, randomized, controlled trials of primary chemoprevention of prostate cancer. RESULTS: With extended post-intervention follow-up, SELECT demonstrated a 17% increased risk of prostate cancer ...

and more »

Read more...